Primary Record
cilostazol
- In stock
- 3,810 g
- Purity
- 98.3 %
- CAS
- 73963-72-1
Compound Identifiers & Properties
- CAS
- 73963-72-1
- PubChem CID
- 2754
- SMILES
- C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4
- Canonical SMILES
- O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1
Names & Synonyms
- cilostazol
- Pletal
- Cilostazole
- Pletaal
- 73963-72-1
- Cilostazolum
- Cilostazol-d11
- Cilosinamin
- Cilosmerck
- Ciloslet
- Cilostate
- Fantezole
- Hordazol
- Kortrythm
- Platemeel
- Plestazol
- Prelazine
- Rotazona
- Flenied
- Opetarl
- Pletmol
- Ranomin
- Aitant
- Ecbarl
- Ejennu
- Gront
- Cilostazolum [INN-Latin]
- Cilostazol RS
- Cilostazol-d4
- OPC-21
- OPC-13013
- Pletal (TN)
- Pletal, Cilostazol
- Cilostazol [INN:JAN]
- CILASTAZOL
- Pleta (TN)
- Cilostazol (Standard)
- OPC 21
- Tocris-1692
- CILOSTAZOL [MI]
- Opera_ID_488
- RefChem:58562
- C20H27N5O2
- CILOSTAZOL [INN]
- CILOSTAZOL [JAN]
- Spectrum2_001118
- Spectrum3_001170
- Spectrum4_000772
- Spectrum5_001762
- CILOSTAZOL [USAN]
- Lopac-C-0737
- Otsuka brand of cilostazol
- CILOSTAZOL [VANDF]
- DTXSID9045132
- OPC 13013
- CHEBI:31401
- CHEMBL799
- D03VPC
- D0E7MJ
- AC1L1EE2
- CILOSTAZOL [MART.]
- MLS000028470
- CILOSTAZOL [USP-RS]
- CILOSTAZOL [WHO-DD]
- Lopac0_000218
- MFCD00866780
- REGID_for_CID_2754
- SCHEMBL16128
- BSPBio_002759
- DTXCID7025132
- KBioGR_001184
- UNII-N7Z035406B
- MLS000758281
- MLS000759507
- MLS001076067
- MLS002153891
- NSC-758936
- SPECTRUM1505230
- SPBio_001256
- RRGUKTPIGVIEKM-UHFFFAOYSA-N
- Cilostazol (JP18/USP/INN)
- GTPL7148
- orb1310589
- Cilostazol (JP15/USAN/INN)
- CILOSTAZOL [ORANGE BOOK]
- N7Z035406B
- SCHEMBL27771101
- SCHEMBL29389547
- CTK8F0315
- ERK5-3P09
- HSDB 8312
- KBio3_002259
- BRN 3632107
- CID2754
- BCPP000279
- CILOSTAZOL [USP MONOGRAPH]
- HMS1922N15
- HMS2093M14
- HMS2096F16
- HMS2234C06
- HMS3260L17
- HMS3268O09
- HMS3412B18
- HMS3654J13
- HMS3676B18
- HMS3713F16
- HMS5079N07
- Pharmakon1600-01505230
- ACT02663
- BCP03724
- Cilostazol [USAN:USP:INN:BAN:JAN]
- ZINC1552174
- Tox21_110098
- Tox21_500218
- BDBM50225508
- CCG-39646
- EBC-11191
- HY-17464R
- KM1582
- MSK160188
- NCGC00015207-07
- NSC758936
- RW2759
- s1294
- SMR000058428
- 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one
- AKOS015855512
- C20-H27-N5-O2
- Cilostazol, >=98% (HPLC), powder
- OPC 13013; OPC 21; Pletaal
- Tox21_110098_1
- 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one
- AC-4334
- AM90304
- BCP9000530
- Cilostazol, 99% - 100MG 100mg
- CL23867
- CS-1759
- DB01166
- FC03161
- KS-5154
- LP00218
- NSC 758936
- RP18108
- SDCCGSBI-0050206.P003
- NCGC00015207-01
- NCGC00015207-02
- NCGC00015207-03
- NCGC00015207-04
- NCGC00015207-05
- NCGC00015207-06
- NCGC00015207-08
- NCGC00015207-09
- NCGC00015207-10
- NCGC00015207-11
- NCGC00015207-12
- NCGC00015207-25
- NCGC00022153-02
- NCGC00022153-04
- NCGC00022153-05
- NCGC00022153-06
- NCGC00022153-07
- NCGC00260903-01
- AJ-26894
- AK111532
- AN-12078
- CJ-24365
- CPD000058428
- HY-17464
- J23.223H
- SAM001246734
- SAM001247085
- SC-14107
- 3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone
- 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone
- 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
- BCP0726000145
- C 0737
- RETAL;PLETAL;OPC 21;PLETAAL;Cilostal
- SBI-0050206.P002
- 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril
- AB0012441
- AB2000035
- CAS-73963-72-1
- LS-142693
- TC-063580
- TL8005113
- A4337
- C2587
- EU-0100218
- FT-0602474
- FT-0645036
- FT-0665038
- NS00009762
- ST24046323
- SW199053-2
- 6-[4-(1-cyclohexyl-1H-1,2,3,4-tetrazol-5-yl)butoxy]-1,2,3,4-tetrahydroquinolin-2-one
- A10217
- D01896
- F20538
- J90029
- 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one
- AB00382988-14
- AB00382988_15
- AB00382988_16
- 963C721
- A837982
- F862750
- Q258591
- SR-01000003107
- 1073608-02-2
- SR-01000003107-2
- SR-01000003107-4
- SR-01000003107-7
- BRD-K67017579-001-04-2
- BRD-K67017579-001-05-9
- BRD-K67017579-001-07-5
- BRD-K67017579-001-13-3
- BRD-K67017579-001-17-4
- BRD-K67017579-001-26-5
- BRD-K67017579-001-27-3
- BRD-K67017579-001-28-1
- SR-01000003107-10
- 2(1H)-Quionlinone, 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-
- 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone
- Z1501485368
- 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxyl)-3,4-dihydrocarobostyril
- 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
- Cilostazol, United States Pharmacopeia (USP) Reference Standard
- 2(1H)-Quinolinone, 3,4-dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-
- 2(1H)-quinolinone, 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-
- 6-[4-(1-cyclohexyl-1,2,3,4-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
- 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolone
- 6-[4-(l-cyclohexyl-1,2,3,4-tetrazol-5-yl)butoxyl]-3,4-dihydrocarbostyril
- Cilostazol, Pharmaceutical Secondary Standard; Certified Reference Material
- 2(1H)-Quinolinone,6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-
- 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy)-3,4-dihydro-1H-quinolin-2-one
- 6-(4-(1-CYCLOHEXYL-1H-TETRAZOL-5-YL)BUTOXY)QUINOLINE-2,3(1H,4H)-DIONE
- 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butyloxy)-3,4-dihydroquinolin-2(1H)-one
- 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one
- 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-2-oxo-1,2,3,4-tetrahydroquinoline
- 6-[4-(1-Cyclohexyl-1H-tetrazole-5-yl)butoxy]-3,4-dihydroquinoline-2(1H)-one
- 6-[4-(1-Cyclohexyl-5-tetrazolyl)butoxy]-1,2,3,4- tetrahydro-2-oxoquinolinone
- 6-[4-[1-(Cyclohexane-1-yl)-1H-tetrazole-5-yl]butoxy]-3,4-dihydroquinoline-2(1H)-one
- 1215541-47-1
- 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone; 6-[4-(1-Cyclohexyl-1,2,3,4-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril; 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one; Cilostazol; Cilostazole; OPC 13013; OPC 21; Pletaal; Pletal
- 6-[4-[1-(2,2,6,6-tetradeuteriocyclohexyl)tetrazol-5-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
- 73963-62-9
- 89332-50-3